Prognosis of food-induced anaphylaxis in children: A single-center real-life study

被引:2
|
作者
Yaytokgil, Sule Buyuk [1 ]
Celik, Ilknur Kulhas [1 ]
Karaatmaca, Betul [1 ]
Ginis, Tayfur [1 ]
Aydin, Selma Alim [1 ]
Toyran, Muge [1 ]
Misirlioglu, Emine Dibek [1 ]
Civelek, Ersoy [1 ]
机构
[1] Univ Hlth Sci, Ankara City Hosp, Dept Pediat Allergy & Immunol, Ankara, Turkey
关键词
NATURAL-HISTORY; EGG ALLERGY; COWS MILK; IGE; MANAGEMENT; TOLERANCE;
D O I
10.2500/aap.2022.43.210106
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Food allergies are known to resolve over time, but there is little information on the natural history of food-induced anaphylaxis (FIA). Objective: This study aimed to evaluate the natural history of FIA in children and determine the factors that affect prognosis. Methods: Children with FIA who were followed up for at least 3 years, between 2010 and 2020, were included. Patients' families were contacted by telephone to question their child's tolerance status and invite them for reevaluation if uncertain. The patients were grouped as tolerant or persistent according to parent reports or reevaluation results. Logistic regression analysis was performed to determine the factors that affected persistence. Results: The study included 185 patients (62.2% boys) with 243 anaphylactic reactions to various foods. Fifty-eight patients (31%) gained tolerance within a 3-year follow-up period. Tolerance rates were higher in patients with FIA to milk (40%) and egg (43.9%) compared with to tree nuts (18.8%), legumes (5.6%), and/or seafood (11.1%) (p <0.001). In a multivariate analysis, risk factors for persistent FIA were multiple food anaphylaxis (odds ratio [OR] 3.755 [95% confidence interval (CI), 1.134-12.4311; p = 0.030), total IgE > 100 kU/L (OR 5.786195% CI, 2.065-16.2071; p = 0.001), and skin-prick test wheal size > 10 mm (OR 4.569 [95% CI, 1.395-14.964]; p =0 .012) at presentation. Conclusion: Approximately a third of the patients with FIA developed tolerance within 3 years. Clinicians should remember that children with food allergies, even anaphylaxis, may develop tolerance over time. Regular follow up and reevaluation of tolerance status are necessary to avoid unnecessary elimination.
引用
收藏
页码:57 / 63
页数:7
相关论文
共 50 条
  • [1] Food-Induced Anaphylaxis in Asian Children: Study in A Tertiary Care Center
    Chatchatee, Pantipa
    Nantanee, Rapisa
    Ngamphaiboon, Jarungchit
    Suratannon, Narissara
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB154 - AB154
  • [2] Cluster analysis of 505 real-life food-induced anaphylaxis in children reveals two stable clinical phenotypes
    Blazowski, Lukasz
    Jerzynska, Joanna
    Kurzawa, Ryszard
    Kuna, Piotr
    Majak, Pawel
    ALLERGY, 2021, 76 (05) : 1585 - 1588
  • [3] Food-Induced Anaphylaxis among Children Weighing <15 kg: A Single-Center Case Series of the Pediatric Emergency Department
    Tabata, Kenshiro
    Fukuie, Tatsuki
    Narita, Masami
    Inagaki, Shinichiro
    Ohnishi, Shima
    Tsuji, Satoshi
    Kubota, Mitsuru
    Ishiguro, Akira
    Ohya, Yukihiro
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2022, 183 (05) : 507 - 516
  • [4] Food-induced anaphylaxis in infants and children
    Samady, Waheeda
    Trainor, Jennifer
    Smith, Bridget
    Gupta, Ruchi
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (03) : 360 - 365
  • [5] Use of epinephrine in food-induced anaphylaxis in children
    Jarvinen, K. M.
    Shreffler, W. G.
    Sampson, H. A.
    Noone, S.
    Nowak-Wegrzyn, A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) : S29 - S29
  • [6] Food-induced anaphylaxis in children - state of art
    Blazowski, Lukasz
    Kurzawa, Ryszard
    Majak, Pawel
    PEDIATRIA I MEDYCYNA RODZINNA-PAEDIATRICS AND FAMILY MEDICINE, 2021, 17 (01): : 8 - 16
  • [7] "Real-life" outcome of gastrointestinal tumor therapies: A single-center comparative study
    Buratti, Thomas
    Mair, Maximilian
    Muehlberger, Nikolai
    Mitterer, Manfred
    CANCER REPORTS, 2019, 2 (05)
  • [8] Real-life effectiveness and safety of secukinumab in axial spondyloarthritis: a single-center study
    Sun Yuankai
    Wang Jiajia
    Qiu Yulu
    Lin Shiyu
    Wang Fang
    Tan Wenfeng
    中华医学杂志英文版, 2022, 135 (21)
  • [9] Real-life effectiveness and safety of secukinumab in axial spondyloarthritis: a single-center study
    Sun, Yuankai
    Wang, Jiajia
    Qiu, Yulu
    Lin, Shiyu
    Wang, Fang
    Tan, Wenfeng
    CHINESE MEDICAL JOURNAL, 2022, 135 (21) : 2623 - 2624
  • [10] Dupilumab Therapy of Prurigo Nodularis: A Single-Center, Real-Life Observational Study
    Jing, Wenwen
    Yang, Danyang
    Liu, Xin
    Li, Li
    Lu, Tao
    Li, Xiaoli
    DERMATOLOGIC THERAPY, 2023, 2023